Genomic studies of schizophrenia: mapping madness?Genomic studies of schizophrenia: mapping madness?
Mike Owen, Department of Psychological Medicine, Wales College of Medicine, Cardiff University, UK.
Mike Owen, Department of Psychological Medicine, Wales College of Medicine, Cardiff University, UK.
Genetic epidemiology of schizophreniaGenetic epidemiology of schizophrenia
Familial, λs =10 Individual differences in liability are largely genetic
– Heritability 0.6-0.9
Non-genetic factors also important Multi-locus model consistently supported by analysis of
family data Genes with population λs > 3 unlikely Number of susceptibility loci, degree of risk conferred by
each and degree of interaction all unknown
Familial, λs =10 Individual differences in liability are largely genetic
– Heritability 0.6-0.9
Non-genetic factors also important Multi-locus model consistently supported by analysis of
family data Genes with population λs > 3 unlikely Number of susceptibility loci, degree of risk conferred by
each and degree of interaction all unknown
Finding genes for schizophreniaFinding genes for schizophrenia
Linkage
Chromosomal abnormalities
Association
Convergent genomics
Linkage
Chromosomal abnormalities
Association
Convergent genomics
Disease geneD18S21
Published linkagedata 2006
Genomewidesignificant
Multiplepositives
8p22-p21
5q21-q336q21-25
6p24-p22
1q21-q22
1 2 3 4 5 6 7 8
1q42
10 11 12 13 14 15 169
13q32-q34
10p15-p11
10q 25-26
22q11-q22
17 18 19 20 21 22 Y X
17p11-q25
Cardiff schizophrenia sib-pair genome screenCardiff schizophrenia sib-pair genome screen
351 microsatellite markers (10.3 cM) in 354 affected sib-pairs179 (UK), 134 (Sweden), 41 (USA)
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
0 500 1000 1500 2000 2500 3000 3500
cM
LO
D
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Chromosome
Williams et al. Am J Hum Genet 2003
CNPVCFS
Linkage studies of schizophrenia 2006Linkage studies of schizophrenia 2006
Data consistent with observed recurrence risks in relatives
Meta-analysis suggests some consensus
Many underpowered studies on uncertain value
Data consistent with observed recurrence risks in relatives
Meta-analysis suggests some consensus
Many underpowered studies on uncertain value
Larger studies needed for more genes, stronger evidence, interactions and better location
800-1000 ASPs optimal
A number of groups are now seeking genes in currently positive regions
Larger studies needed for more genes, stronger evidence, interactions and better location
800-1000 ASPs optimal
A number of groups are now seeking genes in currently positive regions
Positional genetics and schizophreniaPositional genetics and schizophrenia
Positional Candidates – NRG1, 8p 1
– DTNBP1, 6p 2 – G72 (DAOA), 13q 3
Multiple positive studies as well as negative
No clear pattern of associated alleles or haplotypes
Risk variants not identified
Positional Candidates – NRG1, 8p 1
– DTNBP1, 6p 2 – G72 (DAOA), 13q 3
Multiple positive studies as well as negative
No clear pattern of associated alleles or haplotypes
Risk variants not identified
1. Stefansson et al. 2002; 2. Straub et al. 2002; 3. Chumakov et al. 2002;
G72/G30
22q11-q22
17 18 19 20 21 22 Y X
17p11-q25
13q32-q34
10p15-p11
HTR2A
10 11 12 13 14 15 169
DAO10q 25-26
DRD3
5q21-q336q21-25
DTNBP1
6p24-p22
RGS4
1q21-q22
8p22-p21
1 2 3 4 5 6 7 8
1q42
NRG1
Positional candidate genes for schizophrenia
NRG1 association with schizophreniaNRG1 association with schizophrenia
Tosato, Dazzan and Collier, Schiz. Bull. 2005.
DTNBP1: complex pattern of association findings in schizophrenia
DTNBP1: complex pattern of association findings in schizophrenia
Williams, O’Donovan and Owen, Schiz Bull, 2005,
DTNBP1 and schizophreniaDTNBP1 and schizophrenia
Multiple studies suggest that variation in DTNBP is associated with schizophrenia (11/14 positive).
Protection may be mediated by IQ. No individual SNPs or haplotypes have consistently been
implicated in susceptibility. No systematic study aimed at detecting all common genetic
variation. More studies needed to identify risk variants. Reduced expression of message and protein in schizophrenia –
cause or compensation? Cis-acting elements regulate DTNBP expression.
– Can we relate specific haplotypes to gene expression?
Multiple studies suggest that variation in DTNBP is associated with schizophrenia (11/14 positive).
Protection may be mediated by IQ. No individual SNPs or haplotypes have consistently been
implicated in susceptibility. No systematic study aimed at detecting all common genetic
variation. More studies needed to identify risk variants. Reduced expression of message and protein in schizophrenia –
cause or compensation? Cis-acting elements regulate DTNBP expression.
– Can we relate specific haplotypes to gene expression?
DTNBP1 risk haplotype is associated with reduced expression
DTNBP1 risk haplotype is associated with reduced expression
Allele ratios at SNP rs1047631, stratified by heterozygosity for the defined schizophrenia risk haplotype.
Schizophrenia risk haplotype tags one or more cis-acting variants that result in a relative reduction in DTNBP1 mRNA expression in human cerebral cortex.
Further analyses suggest that risk haplotypes identified in other Caucasian samples also index lower DTNBP1 expression.
Ties risk haplotypes to altered function
Suggests explanation for some of the discrepancies between studies
Allele ratios at SNP rs1047631, stratified by heterozygosity for the defined schizophrenia risk haplotype.
Schizophrenia risk haplotype tags one or more cis-acting variants that result in a relative reduction in DTNBP1 mRNA expression in human cerebral cortex.
Further analyses suggest that risk haplotypes identified in other Caucasian samples also index lower DTNBP1 expression.
Ties risk haplotypes to altered function
Suggests explanation for some of the discrepancies between studies
0
0.2
0.4
0.6
0.8
1
1.2
Rat
io A
/G
Genomic cDNA: risk het
cDNA:non risk
Bray et al, Human Molecular Genetics, 2005.
G72/G30
COMT
PRODH
22q11-q22
17 18 19 20 21 22 Y X
13q32-q34
10p15-p11
HTR2A
10 11 12 13 14 15 169
DAO
DRD3
5q21-q336q21-25
DTNBP1
6p24-p22
RGS4
1q21-q22
8p22-p21
1 2 3 4 5 6 7 8
1q42
NRG1
Chromosomal abnormalities and schizophrenia
VCFS and Schizophrenia
25+% of adults with VCFS develop schizophrenia (Murphy et al 2000)
Does a gene on 22q11 predispose to schizophrenia in the general population?
Some claims (COMT, PRODH, ZDHHC8, ARVCF) but none convincing
DISC1 and schizophrenia (Porteous, Millar, Blackwood, St Clair et al)
DISC1 and schizophrenia (Porteous, Millar, Blackwood, St Clair et al)
• DISC1: unknown function; N globular domain; C -helical domain with coiled coil domains; widely expressed, adult > fetal
• DISC2: unknown function; RNA >15kb but no ORF; putative anti-sense RNA regulator of DISC1; widely expressed, heart >> other
• TRAX: translin related protein X; putative role in single strand DNA repair and RNA translocation; intergenic splicing to DISC1
Schizophrenia Associated t(1:11) Translocation
High density of genes around ch#1 breakpoint
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 2 3 4 5 6 7 8 9 10 11 12
1 2 3 4 5 6
1 2I
II
II
VI
V
ASSOCIATION OF A BALANCED AUTOSOMAL TRANSLOCATION t(1;11)
WITH MAJOR MENTAL ILLNESS
Schizophrenia Bipolar
Disorder
Recurrent
Major
Depression
Adolescent
Conduct
Disorder
Anxiety, Alcoholism,
Minor Depression
Translation
t(1;11) Carrier
Possibility of position effect Evidence for haplotype association
with SZ Associations with visual and
working memory deficits t (1,16) disrupts PDE4B (binding
partner of DISC1) in family with psychosis (Millar et al 2005)
DISC1 complex protein associated with numerous cytoskeletal proteins involved in centrosomal and microtubule function, and with cell migration, neurite outgrowth, and membrane trafficking of receptors and possibly mitochondrial function.
Possibility of position effect Evidence for haplotype association
with SZ Associations with visual and
working memory deficits t (1,16) disrupts PDE4B (binding
partner of DISC1) in family with psychosis (Millar et al 2005)
DISC1 complex protein associated with numerous cytoskeletal proteins involved in centrosomal and microtubule function, and with cell migration, neurite outgrowth, and membrane trafficking of receptors and possibly mitochondrial function.
Candidate genes for schizophreniaCandidate genes for schizophrenia
NRG1 and DTNBP1: multiple positive studies. DAOA(G72): some positives for both schizophrenia and bipolar disorder DISC1: highly promising. Effect sizes small-moderate (OR 1.3-2) RGS4: some positives but support weakening. COMT, PRODH, ZDHHC8, PPP3CC, CAPON, CHRNA7, TRAR4 and
others: not yet convincing. Cannot be explained by variants with manifest functional consequences.
– Presumably effects on expression, splicing etc. Remain cautious until risk variants identified. Inconsistencies between studies.
– Lack of power– Genotyping error– Stratification– Incomplete genetic information from indirect studies
» NB dysbindin– Susceptibility variants on different backgrounds??– Allelic heterogeneity/complexity– Heterogeneity: differences in case definition and ascertainment
It’s epidemiology now!
NRG1 and DTNBP1: multiple positive studies. DAOA(G72): some positives for both schizophrenia and bipolar disorder DISC1: highly promising. Effect sizes small-moderate (OR 1.3-2) RGS4: some positives but support weakening. COMT, PRODH, ZDHHC8, PPP3CC, CAPON, CHRNA7, TRAR4 and
others: not yet convincing. Cannot be explained by variants with manifest functional consequences.
– Presumably effects on expression, splicing etc. Remain cautious until risk variants identified. Inconsistencies between studies.
– Lack of power– Genotyping error– Stratification– Incomplete genetic information from indirect studies
» NB dysbindin– Susceptibility variants on different backgrounds??– Allelic heterogeneity/complexity– Heterogeneity: differences in case definition and ascertainment
It’s epidemiology now!
Emil Kraepelin, 1896, splits psychosis.Emil Kraepelin, 1896, splits psychosis.
“crystallized dementia praecox and manic-depressive illness from an amorphous mass of madness” (Brockington & Leff, 1979).
Organic Functional
– Dementia Praecox– Manic-depressive insanity
“crystallized dementia praecox and manic-depressive illness from an amorphous mass of madness” (Brockington & Leff, 1979).
Organic Functional
– Dementia Praecox– Manic-depressive insanity
Deconstructing Psychosis: Challenges to the Kraepelinian Dichotomy.
Deconstructing Psychosis: Challenges to the Kraepelinian Dichotomy.
• No “point of rarity”• Risk factors in common (Murray et al 2004)• Familial co-occurrence of SZP, SA and BP• Cardno et al twin study• Overlapping linkage regions
• 13q, 22q, 6q
New genetic studies confirm this and suggest association with clinical syndromes.
• No “point of rarity”• Risk factors in common (Murray et al 2004)• Familial co-occurrence of SZP, SA and BP• Cardno et al twin study• Overlapping linkage regions
• 13q, 22q, 6q
New genetic studies confirm this and suggest association with clinical syndromes.
Studying candidate genes across the Kraepelinian divide: Dysbindin.
Studying candidate genes across the Kraepelinian divide: Dysbindin.
No association between BP and the Cardiff haplotype in DTNBP1.
Suggestive evidence for association with BP with predominant psychosis.
No association between BP and the Cardiff haplotype in DTNBP1.
Suggestive evidence for association with BP with predominant psychosis.
Raybould et al, Biological Psychiatry, 57: 696-701, 2005.
1
1.05
1.1
1.15
1.2
1.25
1.3
1.35
1.4
1.45
0 20 40 60 80 100
P dimension
Od
ds
ra
tio
Upward trend: p = 0.014
Studying candidate genes across the Kraepelinian divide: Neuregulin.
Studying candidate genes across the Kraepelinian divide: Neuregulin.
NRG1 HAPICE confers risk to illness with both schizophrenia and mood features.
Effect size of NRG1 HAPICE increases with preponderance of mood-incongruent psychotic symptoms (sign test p=0.002).
NRG1 HAPICE confers risk to illness with both schizophrenia and mood features.
Effect size of NRG1 HAPICE increases with preponderance of mood-incongruent psychotic symptoms (sign test p=0.002).
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
BP
SZP
Phenotype
Od
ds
ra
tio
Odds ratio
BP
-IP
BP
-NIP
SZP
-M
SZP
-NM
BP
-IP
& S
ZP-M
BP
-NIP
& S
ZP-N
M
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
BP
SZP
Phenotype
Od
ds
ra
tio
Odds ratio
BP
-IP
BP
-NIP
SZP
-M
SZP
-NM
BP
-IP
& S
ZP-M
BP
-NIP
& S
ZP-N
M
1
1.2
1.4
1.6
1.8
2
2.2
0 10 20 30 40
I dimension
Od
ds
ra
tio
(O
R)
OR
Green et al, Archives of General Psychiatry, 2005.
Studying candidate genes across the Kraepelinian divide: G72 (DAOA).
Studying candidate genes across the Kraepelinian divide: G72 (DAOA).
Some positive replications of G72 but no clear associated alleles or haplotypes.
Independent support for association with Bipolar disorder in several studies.– G72 probably strongest candidate gene for BP.
Is this a gene for both disorders?
Some positive replications of G72 but no clear associated alleles or haplotypes.
Independent support for association with Bipolar disorder in several studies.– G72 probably strongest candidate gene for BP.
Is this a gene for both disorders?
DAOA (G72) in schizophrenia and bipolar disorder
DAOA (G72) in schizophrenia and bipolar disorder
Significant whole gene association in BP (n=706, p=0.045) but not SZ (n=709) vs controls (n=1416).
Significant whole gene association in “Mood” (n= 1153, p=0.0086) and in schizophrenia-mood (n=112, p=0.02) but not psychosis (n=818).
DAOA is probably a susceptibility locus for mood disorder rather than schizophrenia per se.
Extent to which association seen in schizophrenia depends upon clinical characteristics of sample.
Significant whole gene association in BP (n=706, p=0.045) but not SZ (n=709) vs controls (n=1416).
Significant whole gene association in “Mood” (n= 1153, p=0.0086) and in schizophrenia-mood (n=112, p=0.02) but not psychosis (n=818).
DAOA is probably a susceptibility locus for mood disorder rather than schizophrenia per se.
Extent to which association seen in schizophrenia depends upon clinical characteristics of sample.
(Williams et al Archives of General Psychiatry, 2006).
DISC1 is associated with broad psychosis and mood phenotype.
DISC1 is associated with broad psychosis and mood phenotype.
t(1:11) segregates with Sz, BP and UP.
Linkage to SA– Hamshere et al 2005.
Evidence for haplotype association– Hennah et al 2003– Hodgkinson et al 2004
» Schizophrenia, SA and BP– Thomson et al 2005
» SZ and BP.
t(1:11) segregates with Sz, BP and UP.
Linkage to SA– Hamshere et al 2005.
Evidence for haplotype association– Hennah et al 2003– Hodgkinson et al 2004
» Schizophrenia, SA and BP– Thomson et al 2005
» SZ and BP.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 2 3 4 5 6 7 8 9 10 11 12
1 2 3 4 5 6
1 2I
II
II
VI
V
ASSOCIATION OF A BALANCED AUTOSOMAL TRANSLOCATION t(1;11)
WITH MAJOR MENTAL ILLNESS
Schizophrenia Bipolar Disorder
RecurrentMajor
Depression
AdolescentConduct Disorder
Anxiety, Alcoholism,Minor Depression
Translationt(1;11) Carrier
Using genetics to dissect psychosisUsing genetics to dissect psychosis
Craddock, O’Donovan and Owen, Schizophrenia Bulletin, 2006.
Do genetic findings in psychosis point to a common mechanism?Do genetic findings in psychosis point to a common mechanism?
The genes most clearly implicated (NRG1, DTNBP1, G72) all code for proteins that potentially impact, directly or indirectly, on the function of glutamate synapses. Harrison and Owen, Lancet, 2003.
But caution required!– proteins implicated poorly
understood – multiple processes implicated for
NRG1 and DTNBP1
The genes most clearly implicated (NRG1, DTNBP1, G72) all code for proteins that potentially impact, directly or indirectly, on the function of glutamate synapses. Harrison and Owen, Lancet, 2003.
But caution required!– proteins implicated poorly
understood – multiple processes implicated for
NRG1 and DTNBP1
White matter abnormalities in schizophrenia (Mt. Sinai Conte Center)
White matter abnormalities in schizophrenia (Mt. Sinai Conte Center)
Imaging studies– Defects of connectivity– DTI
Multiple gene expression studies in postmortem schizophrenia brains have found significant reduction of expression of myelin and oligodendrocyte related genes (e.g. Hakak et al., 2001)
Quantitative anatomical analyses have demonstrated decreased oligodendrocyte numbers in prefrontal cortex (Hof et al 2002, 2003).
Cause or effect?
Imaging studies– Defects of connectivity– DTI
Multiple gene expression studies in postmortem schizophrenia brains have found significant reduction of expression of myelin and oligodendrocyte related genes (e.g. Hakak et al., 2001)
Quantitative anatomical analyses have demonstrated decreased oligodendrocyte numbers in prefrontal cortex (Hof et al 2002, 2003).
Cause or effect?
CNP is marker for oligodendrocytes
Message and protein show reduced brain expression in schizophrenia
Located at 17q21.2 rs2070106 is associated with CNP
expression (P=0.001). the lower-expressing allele was
significantly associated with schizophrenia (P=.04) in a case-control sample.
All affected individuals in a linked pedigree were homozygous for the lower-expression allele (P=.03).
CNP is marker for oligodendrocytes
Message and protein show reduced brain expression in schizophrenia
Located at 17q21.2 rs2070106 is associated with CNP
expression (P=0.001). the lower-expressing allele was
significantly associated with schizophrenia (P=.04) in a case-control sample.
All affected individuals in a linked pedigree were homozygous for the lower-expression allele (P=.03).
Archives of General Psychiatry (2006) 63: 18-24.
Oligodendrocyte Lineage Transcription Factor 2 (OLIG2): a master regulator of all stages of oligodendrocyte lineage.
Oligodendrocyte Lineage Transcription Factor 2 (OLIG2): a master regulator of all stages of oligodendrocyte lineage.
Basic helix–loop–helix transcription factor central to oligodendrocyte development
Down-regulated in schizophrenia (Tchakev et al, 2003; Katsel et al, 2005; Iwamoto et al, 2005)
Centrality in OL allows for a primary change responsible for several others (parsimony)
Basic helix–loop–helix transcription factor central to oligodendrocyte development
Down-regulated in schizophrenia (Tchakev et al, 2003; Katsel et al, 2005; Iwamoto et al, 2005)
Centrality in OL allows for a primary change responsible for several others (parsimony)
OLIG2 associated with schizophrenia: non redundant (r2<0.9) positives (submitted).
OLIG2 associated with schizophrenia: non redundant (r2<0.9) positives (submitted).
Meff = 9 (all 16 pooled SNPs) gene corrected p = 0.0009 Experiment-wide corrections p = 0.013 (primary 14 genes)
p = 0.038 (all 44 genes)
CONSERVATIVE
ConclusionsConclusions
Some highly promising findings (NRG1, DTNBP1, G72/DAOA, DISC1)
Need to establish risk nucleotides/mechanisms » And this might not be easy without functional readout
(endophenotypic, animal, cellular)» Needs more detailed studies, collaboration, re-sequencing» Expect allelic heterogeneity, effects of ascertainment
Refining the associated phenotype by iteration (Symptoms, Course and outcome, Cognitive function, Imaging). NB samples.
Curation of association data (it’s epidemiology)– Quality standards– Meta-analysis
Need to support genetic associations with biology– DTNBP1 and NRG1 expression studies
Some highly promising findings (NRG1, DTNBP1, G72/DAOA, DISC1)
Need to establish risk nucleotides/mechanisms » And this might not be easy without functional readout
(endophenotypic, animal, cellular)» Needs more detailed studies, collaboration, re-sequencing» Expect allelic heterogeneity, effects of ascertainment
Refining the associated phenotype by iteration (Symptoms, Course and outcome, Cognitive function, Imaging). NB samples.
Curation of association data (it’s epidemiology)– Quality standards– Meta-analysis
Need to support genetic associations with biology– DTNBP1 and NRG1 expression studies
FutureFuture
There are more significant linkages to account for.– Few if any exhaustive fine mapping studies
WGAs– Depend on CDCV hypothesis– Need very large samples– Sample characteristics will be crucial– Data handling and statistical challenges are huge– WTCCC
CNV analysis Candidate pathway analysis (GxG) Inclusion of E in genetic studies (GxE) WGS (CDRV) Understanding gene regulation (identifying regulatory sequences,
miRNA, chromatin effects etc)
There are more significant linkages to account for.– Few if any exhaustive fine mapping studies
WGAs– Depend on CDCV hypothesis– Need very large samples– Sample characteristics will be crucial– Data handling and statistical challenges are huge– WTCCC
CNV analysis Candidate pathway analysis (GxG) Inclusion of E in genetic studies (GxE) WGS (CDRV) Understanding gene regulation (identifying regulatory sequences,
miRNA, chromatin effects etc)
AcknowledgementsAcknowledgements
N Williams N Norton H Williams N Bray A Preece J Wilkinson S Dwyer Elaine Green Rachel Raybould Detelina Grozeva T Peirce B Glaser L Carroll
N Williams N Norton H Williams N Bray A Preece J Wilkinson S Dwyer Elaine Green Rachel Raybould Detelina Grozeva T Peirce B Glaser L Carroll
M O’Donovan N Craddock G Kirov I Jones
M Hamshere, P Holmans. S Macgregor, V Moskvina,
M O’Donovan N Craddock G Kirov I Jones
M Hamshere, P Holmans. S Macgregor, V Moskvina,